Long-term Outcome After Intravenous Thrombolysis of Basilar Artery Occlusion

Occlusion of the basilar artery (BAO) is a relatively infrequent but the most catastrophic form of ischemic stroke with a dismal natural course, carrying from 85 to almost 95 % mortality. Complete BAO precipitates a sudden or gradually worsening clinical syndrome with bilateral motor weaknesses, visual or speech disturbances, deficits in motor coordination and balance, and often leads to reduced consciousness. The most devastating end-point is the locked-in state, in which the patient is conscious but can move only his or her eyes. Many stroke centers have in the past used invasive, intra-arterial thrombolysis to recanalize BAO, which is limited to hospitals with immediate invasive radiologist service.

Previous reports have advocated thrombolytics delivered with invasive endovascular approach to the occlusion site, but even a short delay in the onset of therapy has been reported to be the single most critical factor affecting outcome. Due to unacceptable treatment delays, Finnish neurologists led by Docent Perttu J. Lindsberg and Professor Markku Kaste at Helsinki University Central Hospital reverted from intra-arterial approach to noninvasive, intravenous delivery of alteplase, a protocol used more commonly in anterior circulation strokes. The results of this study were published 20.10.2004 in JAMA (Journal of American Medical Association).

Since 1995, 50 patients with proven BAO were treated in Helsinki according to institutional thrombolysis protocol. By 3 months, 20 patients (40%) died, while 12 patients (24%) reached independence in activities of daily life. On the long-term, patients with recanalized basilar artery and fair outcome continued to improve functionally and survivors reported unexpectedly satisfactory ratings of the quality of their daily life.

Rates of survival, recanalization and independent functional outcome are at least equally good than reported with endovascular invasive approaches, but the benefits of intravenous therapy are that it can start thrombolysis faster and can be used more widely than the invasive approaches.

Media Contact

Paivi Lehtinen alfa

More Information:

http://www.helsinki.fi

All latest news from the category: Health and Medicine

This subject area encompasses research and studies in the field of human medicine.

Among the wide-ranging list of topics covered here are anesthesiology, anatomy, surgery, human genetics, hygiene and environmental medicine, internal medicine, neurology, pharmacology, physiology, urology and dental medicine.

Back to home

Comments (0)

Write a comment

Newest articles

Lighting up the future

New multidisciplinary research from the University of St Andrews could lead to more efficient televisions, computer screens and lighting. Researchers at the Organic Semiconductor Centre in the School of Physics and…

Researchers crack sugarcane’s complex genetic code

Sweet success: Scientists created a highly accurate reference genome for one of the most important modern crops and found a rare example of how genes confer disease resistance in plants….

Evolution of the most powerful ocean current on Earth

The Antarctic Circumpolar Current plays an important part in global overturning circulation, the exchange of heat and CO2 between the ocean and atmosphere, and the stability of Antarctica’s ice sheets….

Partners & Sponsors